Literature DB >> 21763074

Role of the microenvironment in hepatocellular carcinoma development and progression.

Sheng-Di Wu1, Yu-Shui Ma, Ying Fang, Li-Li Liu, Da Fu, Xi-Zhong Shen.   

Abstract

Hepatocellular carcinoma (HCC) is the most common form of liver cancer throughout the world. The microenvironment of the HCC is composed of non-tumor cells and their stroma, with the stroma having been implicated in the regulation of tumor growth, metastatic potential and outcome following therapy. Thus, the tumor microenvironment has become an important target for HCC treatment. In this review article, we will discuss the cellular and molecular components of the hepatoma microenvironment, effects on tumor development and progression, the relationship to prognosis, and the implications for targeting of this microenvironment in the control of HCC. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21763074     DOI: 10.1016/j.ctrv.2011.06.010

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


  53 in total

Review 1.  Immunological landscape and immunotherapy of hepatocellular carcinoma.

Authors:  Jesús Prieto; Ignacio Melero; Bruno Sangro
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-10-20       Impact factor: 46.802

2.  Morphological study and comprehensive cellular constituents of milky spots in the human omentum.

Authors:  Jiu-Yang Liu; Jing-Ping Yuan; Xia-Fei Geng; Ai-Ping Qu; Yan Li
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

3.  Association of abnormal plasma bilirubin with aggressive hepatocellular carcinoma phenotype.

Authors:  Brian I Carr; Vito Guerra; Edoardo G Giannini; Fabio Farinati; Francesca Ciccarese; Gian Ludovico Rapaccini; Maria Di Marco; Luisa Benvegnù; Marco Zoli; Franco Borzio; Eugenio Caturelli; Maria Chiaramonte; Franco Trevisani
Journal:  Semin Oncol       Date:  2014-03-06       Impact factor: 4.929

4.  Macro- and micro-environmental factors in clinical hepatocellular cancer.

Authors:  Petr Pancoska; Brian I Carr
Journal:  Semin Oncol       Date:  2014-03-07       Impact factor: 4.929

Review 5.  Stem Cell Therapy for Hepatocellular Carcinoma: Future Perspectives.

Authors:  Hoda Elkhenany; Ahmed Shekshek; Mohamed Abdel-Daim; Nagwa El-Badri
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 6.  Role of innate immunity in the development of hepatocellular carcinoma.

Authors:  Rajagopal N Aravalli
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

7.  Connective tissue growth factor is overexpressed in human hepatocellular carcinoma and promotes cell invasion and growth.

Authors:  Ming Xiu; Ya-Hui Liu; David R Brigstock; Fang-Hui He; Rui-Juan Zhang; Run-Ping Gao
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

8.  MicroRNA-33a downregulation is associated with tumorigenesis and poor prognosis in patients with hepatocellular carcinoma.

Authors:  Ru-Ting Xie; Xian-Ling Cong; Xiao-Ming Zhong; Ping Luo; Hui-Qiong Yang; Gai-Xia Lu; Pei Luo; Zheng-Yan Chang; Ran Sun; Ting-Miao Wu; Zhong-Wei Lv; Da Fu; Yu-Shui Ma
Journal:  Oncol Lett       Date:  2018-01-29       Impact factor: 2.967

Review 9.  Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma.

Authors:  Virginia Hernandez-Gea; Sara Toffanin; Scott L Friedman; Josep M Llovet
Journal:  Gastroenterology       Date:  2013-01-09       Impact factor: 22.682

Review 10.  Establishment of animal models with orthotopic hepatocellular carcinoma.

Authors:  Tai Kyoung Lee; Kyung Sook Na; Jeonghun Kim; Hwan-Jeong Jeong
Journal:  Nucl Med Mol Imaging       Date:  2014-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.